American Thinker
•categories.
categories.
Reduced drug prices have unacceptable cost
Summary
Nutrition label
59% Informative
The Biden administration recently released their list of the first ten drugs on the Health and Human Services’ price chopping block.
Deane Waldman , M.D. , MBA is Professor Emeritus of Pediatrics, Pathology, and Decision Science .
Waldman: Reductions in out-of-pocket drug spending will start in 2026 , but the true cost will be felt much later.
VR Score
64
Informative language
64
Neutral language
3
Article tone
formal
Language
English
Language complexity
53
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
detected
Time-value
short-lived
External references
9
https://www.politico.eu/article/europe-medicines-industry-dying-pharma/https://publichealth.jhu.edu/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab#:~:text=The%20%2419%20million%20median%20figure,between%20%242%20to%20%243%20billion.https://www.hhs.gov/about/news/2023/08/29/hhs-selects-the-first-drugs-for-medicare-drug-price-negotiation.htmlhttps://www.deanewaldman.com/cureforhealthcare.htmlhttps://creativecommons.org/publicdomain/mark/1.0/https://pharmanewsintel.com/features/understanding-us-food-and-drug-administration-fda-approval-processeshttps://www.economicshelp.org/blog/glossary/command-economy/https://www.wsj.com/health/pharma/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20bhttps://www.youtube.com/watch?v=aA9psql028o
Source diversity
9